Breaking the Bank: Financial Toxicity in Oncology

<p>Allison Golbach, Pharm.D., BCPS (<a href='https://twitter.com/AllisonGPharmD'>@AllisonGPharmD</a>) reviews the definition, background, and measurement of financial toxicity, discusses the impact of financial toxicity on patients’ clinical outcomes, and identifies methods to help patients make informed decisions about their oncology care.</p> <p>For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs <a href='https://twitter.com/MayoPharmRes'>@MayoPharmRes</a> or the host, Garrett E. Schramm, Pharm.D., <a href='https://twitter.com/garrett_schramm'>@garrett_schramm</a> on Twitter!</p> <p>You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>